跳至主要内容
临床试验/jRCT2071260002
jRCT2071260002招募中不适用

A Phase 2 Open-Label, Single Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis)

未提供0 个研究点目标入组 24 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study

入排标准

年龄范围
2age old over 至 12age old not(—)
性别
All

入选标准

  • Have a diagnosis of ulcerative colitis (UC) that is moderately to severely active Participants are permitted to be receiving a therapeutic dose of select UC therapies

排除标准

  • Severe extensive colitis Diagnosis of Crohn's disease (CD) or indeterminate colitis or the presence or history of a fistula consistent with CD Diagnosis of microscopic colitis, ischemic colitis, or infectious colitis

研究者

发起方
未提供

相似试验